Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Published in: Neurotherapeutics 1/2009

01-01-2009 | Review Article

Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease

Authors: Maria Laura Bolognesi, Andrea Cavalli, Carlo Melchiorre

Published in: Neurotherapeutics | Issue 1/2009

Login to get access
Metadata
Title
Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease
Authors
Maria Laura Bolognesi
Andrea Cavalli
Carlo Melchiorre
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 1/2009
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1016/j.nurt.2008.10.042

Other articles of this Issue 1/2009

Neurotherapeutics 1/2009 Go to the issue

Review Article

Polycyclic compounds: Ideal drug scaffolds for the design of multiple mechanism drugs?

Review Article

Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease

Review Article

Novel anti-Alzheimer’s dimer bis(7)-Cognitin: Cellular and molecular mechanisms of neuroprotection through multiple targets

Review Article

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

Program

Second Annual Huntington Disease Clinical Research Symposium

Review Article

Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs